Aldoxorubicin has effective antitumor activities in various cancer cell lines and in murine tumor models. Aldoxorubicin is an albumin-binding prodrug of Doxorubicin (DNA topoisomerase II inhibitors).
Daunorubicin is a topoisomerase II inhibitor with antitumor activity. Daunorubicin can affect DNA and RNA metabolism and synthesis. It is an anthracycline antibiotic that can be used to study infections and many cancers.